Publicacións nas que colabora con Mario Páramo Fernández (16)

2018

  1. Identification of putative second genetic hits in schizophrenia carriers of high-risk copy number variants and resequencing in additional samples

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 6, pp. 585-592

  2. The role of emotion dysregulation in Conversion Disorder

    Actas Espanolas de Psiquiatria, Vol. 46, Núm. 3, pp. 92-103

2016

  1. Emotion regulation strategies in trauma-related disorders: Pathways linking neurobiology and clinical manifestations

    Reviews in the Neurosciences, Vol. 27, Núm. 4, pp. 385-395

  2. Excitatory and inhibitory conversive experiences: Neurobiological features involving positive and negative conversion symptoms

    Reviews in the Neurosciences, Vol. 27, Núm. 1, pp. 101-110

  3. Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states

    Schizophrenia Research, Vol. 174, Núm. 1-3, pp. 10-16

2015

  1. An efficient screening method for simultaneous detection of recurrent copy number variants associated with psychiatric disorders

    Clinica Chimica Acta, Vol. 445, pp. 34-40

  2. Cumulative role of rare and common putative functional genetic variants at NPAS3 in schizophrenia susceptibility

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 168, Núm. 7, pp. 528-535

  3. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility

    Journal of Psychiatric Research, Vol. 66-67, pp. 38-44

2014

  1. Absence of low frequency variants associated with schizophrenia at the ultraconserved non-coding region of TCF4

    Psychiatry Research

2013

  1. Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs

    Annals of Human Genetics, Vol. 77, Núm. 6, pp. 504-512

2012

  1. Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia

    Biological Psychiatry, Vol. 71, Núm. 2, pp. 169-177

  2. No evidence that major mtDNA European haplogroups confer risk to schizophrenia

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 159 B, Núm. 4, pp. 414-421

2011

  1. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: New data and meta-analysis

    Journal of Psychiatric Research, Vol. 45, Núm. 1, pp. 7-14

  2. Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain

    Schizophrenia Research, Vol. 127, Núm. 1-3, pp. 22-27

2010

  1. Testing the antagonistic pleiotropy model of schizophrenia susceptibility by analysis of DAOA, PPP1R1B, and APOL1 genes

    Psychiatry Research, Vol. 179, Núm. 2, pp. 126-129

2007

  1. Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population

    Schizophrenia Research, Vol. 90, Núm. 1-3, pp. 123-129